**Study: Only 38% of Nations Worldwide Use Risk-Based Pneumococcal Vaccine Policies**
A new study reveals that a minority of countries worldwide have adopted risk-based policies for pneumococcal vaccination. Specifically, researchers found that only 38% of nations have implemented vaccine policies that target individuals based on their specific risk factors for pneumococcal disease. The study examined pneumococcal vaccine policies across different nations. The findings highlight that a significant portion of countries have yet to adopt the risk-based approach in their pneumococcal vaccination strategies.
Newsflash | Powered by GeneOnline AI
Date: May 10, 2025
LATEST
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20